Unnamed Project
Award Notice Posted
- Solicitation number
- W911QY-13-C-0056
- Agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Awarded
- to Dynport Vaccine Company LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W911QY-13-C-0056 Federal contract award
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
2 versions
Update #2 · Latest ·
Added: May 10, 2013 2:19 pm Modified: May 10, 2013 2:37 pmTrack Changes Input incorrectly.
Update #1 ·
Added: May 10, 2013 2:19 pm
This contract action was not awarded as a fixed price type because uncertainties involved in contract performance did not permit costs to be estimated with sufficient accuracy to use any type of fixed price contract. As such, a cost-reimbursement type action was awarded (FAR 16.301-2).
FDA approved countermeasure that will increase the likelihood that a Warfighter will maintain operational effectiveness following nerve agent exposure, specifically a drug or biologic intended for use prior to an exposure to nerve agent, i.e., a prophylactic countermeasure. It is anticipated that the countermeasure, when administered prior to nerve agent exposure, shall decrease incapacitation and death associated with nerve agent poisoning. Specifically, when administered prior to nerve agent exposure, the countermeasure should prevent injury by binding and sequestering or degrading nerve agent in the circulatory system before it can reach the nervous system.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity